{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:34:21Z","timestamp":1789731261685,"version":"4.0.1"},"reference-count":27,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100001349","name":"MOH | National Medical Research Council","doi-asserted-by":"publisher","award":["CG21APR2005"],"award-info":[{"award-number":["CG21APR2005"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"MOH | National Medical Research Council","doi-asserted-by":"publisher","award":["CG21APR1011"],"award-info":[{"award-number":["CG21APR1011"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","award":["Start-up Grant"],"award-info":[{"award-number":["Start-up Grant"]}],"id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2023,6,15]]},"abstract":"<jats:p>\n            This study determined the susceptibilities of carbapenem-resistant\n            <jats:italic>Enterobacterales<\/jats:italic>\n            isolates to various novel antimicrobial agents (ceftazidime-avibactam, imipenem-relebactam, meropenem-vaborbactam, eravacycline, and plazomicin). Whole-genome sequencing was performed for all strains.\n          <\/jats:p>","DOI":"10.1128\/spectrum.01002-23","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T14:33:50Z","timestamp":1684161230000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":14,"title":["Comparative Activities of Novel Therapeutic Agents against Molecularly Characterized Clinical Carbapenem-Resistant\n            <i>Enterobacterales<\/i>\n            Isolates"],"prefix":"10.1128","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2508-3941","authenticated-orcid":true,"given":"Jocelyn Qi-Min","family":"Teo","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Singapore General Hospital, Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Yi","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Singapore General Hospital, Singapore, Singapore"},{"name":"Department of Clinical Translational Research, Singapore General Hospital, Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si Hui","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Singapore General Hospital, Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng Yee","family":"Tang","sequence":"additional","affiliation":[{"name":"Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick Twee-Hee","family":"Ong","sequence":"additional","affiliation":[{"name":"Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5968-1870","authenticated-orcid":true,"given":"Karrie Kwan Ki","family":"Ko","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Singapore General Hospital, Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimin Jasmine","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuan Tong","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8981-4411","authenticated-orcid":true,"given":"Andrea Lay-Hoon","family":"Kwa","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Singapore General Hospital, Singapore, Singapore"},{"name":"Singhealth Duke-NUS Medicine Academic Clinical Programme, Singapore, Singapore"},{"name":"Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-020-00395-2"},{"key":"e_1_3_2_3_2","unstructured":"U.S. Food and Drug Administration. 2019. Ceftazidime-avibactam. U.S. Food and Drug Administration website. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/206494s005 s006lbl.pdf. Accessed 27 October 2022."},{"key":"e_1_3_2_4_2","unstructured":"U.S. Food and Drug Administration. 2019. Imipenem-cilastatin-relebactam. U.S. Food and Drug Administration website. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/212819s000lbl.pdf. Accessed 27 October 2022."},{"key":"e_1_3_2_5_2","unstructured":"U.S. Food and Drug Administration. 2017. Meropenem-vaborbactam. U.S. Food and Drug Administration website. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/209776lbl.pdf. Accessed 27 October 2022."},{"key":"e_1_3_2_6_2","unstructured":"U.S. Food and Drug Administration. 2018. Eravacycline. U.S. Food and Drug Administration website. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/211109lbl.pdf."},{"key":"e_1_3_2_7_2","unstructured":"U.S. Food and Drug Administration. 2018. Plazomicin. U.S. Food and Drug Administration website. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/210303Orig1s000lbl.pdf. Accessed 27 October 2022."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105883"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2020.05.001"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.01026-20"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","unstructured":"Lam MMC Wick RR Watts SC Cerdeira LT Wyres KL Holt KE. 2021. Genomic surveillance framework and global population structure for Klebsiella pneumoniae. bioRxiv. doi:10.1101\/2020.12.14.422303.","DOI":"10.1101\/2020.12.14.422303"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2018.03.023"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2016.12.008"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/1060028019850173"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-020-00351-0"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac268"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms4010013"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00957-22"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01936-19"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2021.106439"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01443-17"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-3801-1"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00021-18"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2021.106456"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix113"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2021.1968318"},{"key":"e_1_3_2_27_2","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically.","author":"Clinical and Laboratory Standards Institute","year":"2019","unstructured":"Clinical and Laboratory Standards Institute. 2019. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 11th ed, CLSI standard M07. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"11"},{"key":"e_1_3_2_28_2","volume-title":"Performance standards for antimicrobial susceptibility testing.","author":"Clinical and Laboratory Standards Institute","year":"2023","unstructured":"Clinical and Laboratory Standards Institute. 2023. Performance standards for antimicrobial susceptibility testing. 33rd ed, CLSI supplement M100. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"33"}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.01002-23","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.01002-23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T13:24:42Z","timestamp":1686835482000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.01002-23"}},"subtitle":[],"editor":[{"given":"William","family":"Lainhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,6,15]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6,15]]}},"alternative-id":["10.1128\/spectrum.01002-23"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.01002-23","relation":{},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,15]]},"assertion":[{"value":"2023-03-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01002-23"}}